Has Rabbie Hanna received payments from drug or device companies?

Yes. Drug and device makers reported $105,463 in general payments to Rabbie Hanna across 127 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rabbie Hanna did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rabbie Hanna come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rabbie Hanna

Obstetrics & Gynecology · Detroit, MINPI 1164613931

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $85,538 of the $105,463 with a category attached, or 81.1%. 9 manufacturers reported payments, led by Tesaro, Inc. at 38.4% of the total. Reporting peaked in 2019 at $81,692 and has fallen 99.9% since, to $52 in 2023. Among obstetrics & gynecology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$105,463in general payments, 2019–2025

Across 127 payments — averaging $830.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Tesaro, Inc.$40K
Clovis Oncology, Inc.$33K
AstraZeneca$22K
GSK$9K
Asensus Surgical, Inc.$976
Dova Pharmaceuticals$87
plus $85 from 3 others

$315,459in research payments, 2019–2025

Across 25 payments — averaging $12,618 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eisai Inc.$105K
Merck$101K
AstraZeneca$52K
Tesaro, Inc.$39K
GSK$16K
Genentech, Inc.$4K

What the payments were for

Consulting fees$11,28711%
Speaking & faculty fees$85,53881%
Travel & lodging$5,2125%
Food & beverage$3,4263%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Tesaro, Inc.	50	$40,455
Clovis Oncology, Inc.	23	$32,892
AstraZeneca	39	$21,882
GSK	9	$9,087
Asensus Surgical, Inc.	2	$976
Dova Pharmaceuticals	1	$87
Minerva Surgical, Inc	1	$52
Conmed Corporation	1	$20
Merck	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$105,463 in reported general payments places this provider in the 95th percentile of 1,474 obstetrics & gynecology providers in Michigan.

See all obstetrics & gynecology providers in Michigan →

Other obstetrics & gynecology in Detroit

David EisensteinDetroit$272K
Brent DavidsonDetroit$171K
Susan HendrixDetroit$44K
Muhammad AslamDetroit$40K
Neil SimmermanDetroit$14K
Anne SchneiderDetroit$8K
Peter TsengPort Huron$178K
Robert ValiceChesterfield$175K
Michael EngelLake Orion$165K
Ethan GoldsteinBloomfield Hills$140K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →